Large-scale testing (Phase 3)UnknownNCT04309240
What this trial is testing
Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports
Who this might be right for
RivaroxabanThromboprophylaxisCancer
LiuZhou People's Hospital 204